# Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA

> **NCT00653042** · PHASE2 · COMPLETED · sponsor: **Scios, Inc.** · enrollment: 305 (actual)

## Conditions studied

- Coronary Artery Bypass Surgery
- Coronary Heart Disease
- Coronary Artery Bypass Grafting
- Cardiopulmonary Bypass
- Ischemic Heart Disease
- Congestive Heart Failure

## Interventions

- **DRUG:** Nesiritide

## Key facts

- **NCT ID:** NCT00653042
- **Lead sponsor:** Scios, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00653042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00653042, "Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00653042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*